Shin Nippon Biomedical Laboratories Agrees Licensing Nasal Drug Delivery Technology To Tokai Pharmaceuticals

Published: Aug 04, 2006

ShinNippon Biomedical Laboratories' two subsidiaries, Translational Research Ltd.(TRL) and Bioactis Ltd. have signed general terms of agreement for the licensing and supplying of their patented nasal drug delivery technology in the field of endocrinology to Tokai Pharmaceuticals of Massachusetts, USA.

Back to news